Vgl-4 inhibitors represent a specialized class of chemical compounds designed to specifically target and inhibit the Vgl-4 protein. Vgl-4, also known as Vasculin-like 4, is a member of a family of proteins involved in various cellular processes. This protein is characterized by its role in cell signaling and interaction with other proteins within complex molecular pathways. The exact biological function of Vgl-4 may vary depending on the cellular context, but it is typically implicated in processes related to cellular adhesion, migration, and possibly signal transduction.
The mechanism of action for Vgl-4 inhibitors involves binding to specific regions of the Vgl-4 protein, thereby obstructing its normal interactions with other cellular molecules. This inhibition disrupts the protein's ability to participate in its usual biological functions, such as mediating cell adhesion or modulating signal transduction pathways. By interfering with Vgl-4's activity, these inhibitors can affect the broader cellular processes that depend on the protein's normal function. Researchers use Vgl-4 inhibitors to dissect the specific roles of Vgl-4 in cellular and molecular contexts, providing insights into how disruptions in this protein's activity might influence various cellular functions and interactions. Understanding the impact of Vgl-4 inhibition helps clarify the broader implications of this protein's role in cellular dynamics and signaling networks.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits protein synthesis, which could decrease Vgl-4 levels in cells. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Inhibits transcription, potentially lowering Vgl-4 mRNA and protein levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
By inhibiting mTOR, it could reduce protein synthesis including Vgl-4. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
An antimetabolite that could interfere with RNA and protein synthesis, affecting Vgl-4 expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Inhibits DNA synthesis and might indirectly affect Vgl-4 protein expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Hsp90 inhibitor, could affect the stability of proteins interacting with Vgl-4. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
A potent inhibitor of RNA polymerase II, could suppress Vgl-4 transcription. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Causes premature chain termination during translation, affecting protein synthesis including Vgl-4. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Inhibits dihydrofolate reductase, affecting nucleotide synthesis and potentially Vgl-4 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Inhibitor of DNA topoisomerase I, could affect DNA replication and indirectly Vgl-4 expression. |